Evidence map›Paper›PMID 27002976›Full record

ArticlePloS one2016

D-Alanine-Controlled Transient Intestinal Mono-Colonization with Non-Laboratory-Adapted Commensal E. coli Strain HS.

Miguelangel Cuenca, Simona P Pfister, Stefanie Buschor, Firuza Bayramova, Sara B Hernandez, Felipe Cava, Erkin Kuru, Michael S Van Nieuwenhze, Yves V Brun, Fernanda M Coelho and 1 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Transient infection ofApplied and environmental microbiology · 2024
    Article
  5. Review
  6. Article
  7. Engineering Endosymbiotic Growth ofACS synthetic biology · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Miguelangel CuencaInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Simona P PfisterInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Stefanie BuschorInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Firuza BayramovaInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Sara B HernandezLaboratory for Molecular Infection Medicine Sweden, Department of Molecular Biology, Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Felipe CavaLaboratory for Molecular Infection Medicine Sweden, Department of Molecular Biology, Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Erkin KuruDepartment of Chemistry, Indiana University, Bloomington, Indiana, United States of America.
Michael S Van NieuwenhzeDepartment of Chemistry, Indiana University, Bloomington, Indiana, United States of America.
Yves V BrunDepartment of Biology, Indiana University, Bloomington, Indiana, United States of America.
Fernanda M CoelhoInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Siegfried HapfelmeierInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.

Funding

Dynamics of bacterial peptidoglycan synthesisR01GM113172 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI BRUN, YVES V, VANNIEUWENHZE, MICHAEL S · 2015 to 2018
$3.5M
NIGMS NIH HHS R01 GM113172
6 · The paper itself

Abstract

Soon after birth the mammalian gut microbiota forms a permanent and collectively highly resilient consortium. There is currently no robust method for re-deriving an already microbially colonized individual again-germ-free. We previously developed the in vivo growth-incompetent E. coli K-12 strain HA107 that is auxotrophic for the peptidoglycan components D-alanine (D-Ala) and meso-diaminopimelic acid (Dap) and can be used to transiently associate germ-free animals with live bacteria, without permanent loss of germ-free status. Here we describe the translation of this experimental model from the laboratory-adapted E. coli K-12 prototype to the better gut-adapted commensal strain E. coli HS. In this genetic background it was necessary to complete the D-Ala auxotrophy phenotype by additional knockout of the hypothetical third alanine racemase metC. Cells of the resulting fully auxotrophic strain assembled a peptidoglycan cell wall of normal composition, as long as provided with D-Ala and Dap in the medium, but could not proliferate a single time after D-Ala/Dap removal. Yet, unsupplemented bacteria remained active and were able to complete their cell cycle with fully sustained motility until immediately before autolytic death. Also in vivo, the transiently colonizing bacteria retained their ability to stimulate a live-bacteria-specific intestinal Immunoglobulin (Ig)A response. Full D-Ala auxotrophy enabled rapid recovery to again-germ-free status. E. coli HS has emerged from human studies and genomic analyses as a paradigm of benign intestinal commensal E. coli strains. Its reversibly colonizing derivative may provide a versatile research tool for mucosal bacterial conditioning or compound delivery without permanent colonization.

Indexed as

Gastrointestinal TractAlanineAlanine RacemaseAnimalsAutolysisCell WallDiaminopimelic AcidEscherichia coli K12Gastrointestinal MicrobiomeGerm-Free LifeHumansImmunoglobulin AMiceMice, Inbred C57BLMicrobial ConsortiaModels, AnimalAlanineAlanine RacemaseDiaminopimelic AcidImmunoglobulin APeptidoglycan

Identifiers

PMID27002976
PMCPMC4803232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.